Invesaro

Stocks Health care NNOX

NASDAQ · Health care

Nano-X Imaging Ltd. (NNOX)

Nano-X Imaging Ltd. reported revenue of $13M in fiscal 2025, up 15.4% from a year earlier. It posted a net loss of $75M. In fiscal 2025 capital spending exceeded operating cash flow by $45M. At December 31, 2025 it held $49.2M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 30, 2026.

Free, no password. An email when NNOX files with the SEC.

Price
$0.37
+59.80% on the day · November 10, 2026
52-week range $0.21 to $4.71
Market cap
$29.3M
Revenue (FY2025)
$13M
+15.4% year on year
Net margin
-576.1%

Key facts about Nano-X Imaging Ltd.

Net worth
Nano-X Imaging Ltd. has a market value (market cap) of $29.3M at the latest share price, and shareholders' equity of $139.7M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $13M (+15.4% year on year), with a net loss of $75M.
Cash flow
In fiscal 2025 operations used $40.8M of cash.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on April 30, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Nano-X Imaging Ltd. does

Nano-X Imaging Ltd. is registered with the SEC under industry code SIC 3844 (X-Ray Apparatus & Tubes & Related Irradiation Apparatus). Its shares trade on NASDAQ under the ticker NNOX.

Revenue and profit by year

Revenue
FY21: $1.3M $1.3M FY21FY22: $8.6M $8.6M FY22FY23: $9.9M $9.9M FY23FY24: $11.3M $11.3M FY24FY25: $13M $13M FY25
Net income
FY18: -$1.9M -$1.9M FY18FY20: -$22.6M -$22.6M FY20FY20: -$43.8M -$43.8M FY20FY21: -$61.8M -$61.8M FY21FY22: -$113.2M -$113.2M FY22FY23: -$60.8M -$60.8M FY23FY24: -$53.5M -$53.5M FY24FY25: -$75M -$75M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$13M-$78.2M-$75M-$1.16-$45M
2024$11.3M-$56.7M-$53.5M-$0.91-$39.4M
2023$9.9M-$62.6M-$60.8M-$1.08-$48.1M
2022$8.6M-$117.7M-$113.2M-$2.17-$50.6M
2021$1.3M-$61.6M-$61.8M-$1.28-$61.2M
2020n/a-$43.9M-$43.8M-$1.23-$35.5M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where NNOX ranks in Health care

Revenue$13M
#505 of 751 in Health care · Bottom 33%
Revenue growth+15.4%
#225 of 532 in Health care · Top 42%
Net margin-576.1%
#522 of 544 in Health care · Bottom 4%
Free cash flow margin-345.6%
#457 of 490 in Health care · Bottom 7%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Nano-X Imaging Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 2, 2026
  2. September 29, 2026
  3. September 17, 2026
  4. September 9, 2026
  5. August 18, 2026
  6. August 13, 2026
  7. August 7, 2026
  8. August 6, 2026
  9. July 29, 2026
  10. July 23, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 16, 2026. Insider transactions on SEC

Insider trades

What the people running Nano-X Imaging Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $60K worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$60K
last 90 days
Sold
$0
last 90 days
Net bought
80,000
$60K
DateInsiderWhatSharesPriceValueFiling
September 15, 2026 Meltzer ErezChief Executive Officer, Director Boughtindirect 10,000 $0.69 $6.9K Form 4
September 14, 2026 Suesskind Dan SDirector Bought 30,000 $0.76 $22.8K Form 4
September 14, 2026 Suesskind Dan SDirector Bought 30,000 $0.75 $22.5K Form 4
September 10, 2026 Meltzer ErezChief Executive Officer, Director Boughtindirect 10,000 $0.78 $7.8K Form 4
August 10, 2026 Meltzer ErezChief Executive Officer, Director Boughtindirect 9,443 $1.03 $9.7K Form 4
July 29, 2026 Daniel RanCFO Other change 1,000 $0.89 $890 Form 4
July 28, 2026 Kainan NogaDirector Bought 33,000 $0.90 $29.7K Form 4
July 27, 2026 Suesskind Dan SDirector Bought 25,000 $0.94 $23.5K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NNOX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Moalem Moshe13G, passive 7.56% 5,263,161 July 15, 2026

Latest filings below 5%: SK square Co., Ltd. 0% (May 15, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

5 insiders reported holding 285,684 shares in total, about $106.6K at the last price.

HolderSharesAs of
Suesskind Dan SDirector 110,000 September 14, 2026
Meltzer ErezChief Executive Officer, Director 65,44365,443 held indirectly September 15, 2026
Daniel RanCFO 52,374 July 29, 2026
Kainan NogaDirector 40,792 July 28, 2026
Alroy ErezDirector 17,075 June 10, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NNOX

What does Nano-X Imaging Ltd. do?

Nano-X Imaging Ltd. is a company in the Health care sector, listed on NASDAQ as NNOX. Its shares trade on NASDAQ under the ticker NNOX.

What is Nano-X Imaging Ltd.'s net worth?

Nano-X Imaging Ltd. has a market value (market cap) of $29.3M at the latest share price, and shareholders' equity of $139.7M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Nano-X Imaging Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $75M on revenue of $13M.

How much revenue does Nano-X Imaging Ltd. make?

In fiscal 2025 Nano-X Imaging Ltd. reported revenue of $13M. That is 15.4% more than a year earlier.

When did Nano-X Imaging Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 30, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from October 2, 2026.

Similar companies

Compare NNOX with

Compare NNOX with any company

Follow NNOX

Get an email when Nano-X Imaging Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when NNOX files with the SEC.

Where the numbers come from

Financial figures are the values Nano-X Imaging Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.